HERSHBERG ROBERT 4

What Happened
Robert Hershberg, a director of Adaptive Biotechnologies Corp (ADPT), was granted 15,625 shares on March 4, 2026. The Form 4 reports the acquisition as an award/grant (transaction code A) with a reported price of $0.00 (no cash paid).

Key Details

• Transaction date: 2026-03-04; Form 4 filed: 2026-03-06 (filed within the typical 2‑business‑day window).
• Transaction type/code: Award/Grant (A).
• Shares granted: 15,625 shares; reported acquisition price: $0.00 (filing shows $0 cash exchanged).
• Shares owned after transaction: Not specified in the information provided in your request (check the full Form 4 for post-transaction beneficial ownership totals).
• Footnotes/special plans: No 10b5‑1 plan, tax withholding, or other footnotes noted in the provided transaction details.

Context
An award/grant is an issuance of shares to an insider (often as compensation or part of a director equity plan) and does not represent an open‑market purchase or sale. Such grants are routine for compensation and should be interpreted as an issuance rather than a direct bullish purchase; review Adaptive Biotechnologies’ proxy/compensation disclosures for the grant’s purpose and vesting schedule. For full details and any post‑transaction ownership figures, consult the complete Form 4 (Accession No. 0001274139-26-000001).